ALGERT GLOBAL LLC
Position in HRMY — Harmony Biosciences Holdings, Inc.
CIK 1275218
SAN FRANCISCO, CA
Position in HRMY
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$5,273,952
+$2,157,616 QoQ
Shares Held
144,849
+30.2% QoQ
Ownership
0.249%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#60
of 328 holders
Holding Since
Mar 2022
18 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in HRMY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ALGERT GLOBAL LLC holds $633,232,925 across 110 Biotechnology names. HRMY ranks #40 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PCVX |
Vaxcyte, Inc.
|
515,343 | $29,956,888 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
845,118 | $29,908,726 | |
| 3 | XENE |
Xenon Pharmaceuticals Inc.
|
419,773 | $25,337,498 | |
| 4 | CLDX |
Celldex Therapeutics, Inc.
|
647,836 | $24,105,977 | |
| 5 | AXSM |
Axsome Therapeutics, Inc.
|
95,335 | $23,335,147 | |
| 6 | SNDX |
Syndax Pharmaceuticals Inc
|
1,051,465 | $22,985,024 | |
| 7 | MRNA |
Moderna, Inc.
|
274,820 | $19,245,644 | |
| 8 | MLYS |
Mineralys Therapeutics, Inc.
|
649,027 | $17,510,748 |
All Filings in HRMY
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,273,952 | 144,849 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $3,116,336 | 111,258 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $13,464,389 | 359,818 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $7,402,836 | 268,608 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $8,515,820 | 269,488 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $7,097,283 | 213,838 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $7,945,544 | 230,908 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $3,637,640 | 90,941 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $3,095,773 | 102,611 | Shares | Sole | 2024-08-15 | |
| 2024-03-31 | $4,285,177 | 127,611 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $5,172,554 | 160,141 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $1,169,397 | 35,685 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $1,422,203 | 40,415 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $446,162 | 13,665 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $958,354 | 17,393 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $664,482 | 15,003 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $745,449 | 15,285 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $1,229,920 | 25,281 | Shares | Sole | 2022-05-16 | |
| No filing history on record for this holder in this stock. | ||||||